TGFB1 and Parkinson disease: This study was performed as preliminary work to investigate the effect of MP as an anti-parkinsonian remedy in comparison to synthetic L-DOPA, which is clinically used to treat PD by specifically focusing on IL-6, IL-12p40, and TGF-β1.